LAMATTINA JOHN L bought LGND

March 6, 2026 · Form 4 insider transaction

LAMATTINA JOHN L bought 2,161 shares of Ligand Pharmaceuticals Incorporated at $114.15 per share, a transaction worth $246.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 25 days after the transaction.